TCM Limited - agriculture in Kochi, Kerala, India. FY 2026 financials & compliance.
CIN L24299KL1943PLC001192 Incorporated 20 April 1943 ROC Ernakulam HQ Kochi, Kerala, India
Active Listed - BSE: 524156 Public Limited Company agriculture MSME
Data last updated
Market Cap
₹35.85 Cr
TCMLMTD · BSE
Share Price
₹46.50
-10.23% today
Revenue
₹19.74 Cr
FY 2025-26 · -24.1% YoY
EBITDA
−₹4.38 Cr
Margin -22.2%
Net Profit
−₹5.80 Cr
FY 2025-26 · -425.8% YoY
ROE
-21.7%
ROCE -8.9%
Debt / Equity
0.60
Interest cover -41.3x
Authorised capital
₹10 Cr
Registered with MCA

About TCM Limited

Data last updated:

TCM Limited is a public limited company based in Kochi, Kerala, India. It operates in the animal feeds segment of the agriculture sector. It was incorporated on 20 April 1943 and has been in existence for over 83 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN L24299KL1943PLC001192. Its GSTIN is 32AAACT6206A1Z4 (Kerala). The company holds 4 GST registrations, of which 2 are active. Its shares are listed on BSE: 524156.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.48 Cr. It was formerly known as The Travancore Chemical & Manufacturing Company Limited. It is led by directors including Joseph Varghese (Managing Director) and Rani Jose.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kochi, Kerala.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹19.74 Cr, a decline of 24.1% compared to the previous year. For the same year it recorded a net loss of ₹5.8 Cr (net margin -29.4%) and EBITDA of -₹4.38 Cr (EBITDA margin -22.2%). The net worth stands at ₹24.7 Cr (down 19.1% YoY). Total assets are valued at ₹46.18 Cr (up 13.6% YoY).

Its group structure includes 1 subsidiary.

The company is associated with 1 brand: TCM Limited. As per MCA filings, the company has open charges of ₹24.68 Cr and satisfied charges of ₹39.86 Cr on record. Court records list 70 cases involving the company, including 33 filed by the company and 24 filed against it; 7 cases are pending. The company has 18 deals on record (17 market trades, 1 rights issue); the latest was in May 2026. Its 10 peer companies in the Agriculture industry (Animal Feeds, Healthcare Equipment Retail and Distribution, Industrial Chemicals) are compared by revenue, 5 larger and 5 smaller; the largest is Asomiya Mahila Poultry Producer Company Limited with revenue of ₹30.74 Cr.

TCM Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-KL-02-0016285). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tcmlimited.in.

Company Details of TCM Limited
CIN L24299KL1943PLC001192
Registration Number 001192
Incorporation Date 20 April 1943
ROC Ernakulam
Listing Status Listed (BSE: 524156)
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-KL-02-0016285

Recognitions & Rankings of TCM

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-KL-02-0016285
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    House No.28/2917 (Ground Floor) 'Aiswarya' Shanthi Nagar Ponneth Temple Road Kada, Vanthra, Kochi, Kerala, India – 682020
  • Industry
    Agriculture, Animal Feeds
Comprehensive company report
TCM Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full TCM Limited report

Financials, compliance, directors, charges, ownership and filings for TCM Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with TCM Limited

TCM operates one associated brand: TCM Limited. Each brand links to its own profile.

BrandDescriptionWebsite
TCM Limited is engaged in renewable energy, healthcare, and trading.tcmlimited.in

Business Activity of TCM Limited

The main business activity of TCM is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities. 2 activity segments are registered with the MCA.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of TCM Limited FY 2025-26 filings available

TCM Limited reported revenue of ₹19.74 Cr (down 24.1% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹19.74 Cr
-24.1% YoY
EBITDA
−₹4.38 Cr
-103.7% YoY
Profit After Tax
−₹5.80 Cr
-425.8% YoY
Net Worth
₹24.70 Cr
-19.1% YoY
Total Assets
₹46.18 Cr
+13.6% YoY
Total Debt
₹22.16 Cr
+97.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue19.7426.0132.237.353.554.250.92
Revenue growth-24.1%-19.3%+338.5%+107.0%-16.5%+362.0%-
EBITDA(4.38)(2.15)(2.23)(3.66)(6.58)(0.89)(0.83)
EBITDA margin-22.2%-8.3%-6.9%-49.8%-185.4%-20.9%-90.2%
Profit before tax(6.02)1.36(2.26)(4.29)(5.87)0.300.30
Net profit(5.80)1.78(1.96)(3.99)(2.92)(0.07)0.30
Net profit margin-29.4%+6.8%-6.1%-54.3%-82.3%-1.7%+32.6%
EPS (₹)(7.77)2.16(2.61)(5.35)(15.11)0.350.89
Balance sheet
Total assets46.1840.6547.6951.1250.4358.1057.80
Net worth24.7030.5228.7930.7425.3332.5932.47
Total debt22.1611.220.271.446.535.835.64
Cash & bank0.780.410.540.210.280.070.02
Net working capital7.516.289.38(8.23)(6.44)(3.58)(2.55)
Cash flow
Cash from operations(5.22)(10.08)1.95(10.87)(4.21)0.39(0.57)
Cash from investing(3.59)(0.18)(0.64)5.844.22(0.51)0.00
Cash from financing9.0210.37(1.30)4.870.190.18(3.14)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue4.884.925.695.923.217.656.186.90
Revenue growth (YoY)+52.0%-35.7%-7.9%-14.2%-39.2%---
Other income0.060.210.090.600.064.340.060.03
EBITDA(0.98)(1.17)(0.55)(0.83)(1.96)0.05(0.59)(0.58)
EBITDA margin-20.1%-23.8%-9.7%-14.0%-61.1%+0.7%-9.5%-8.4%
Depreciation0.160.180.170.110.100.100.090.08
Interest0.520.500.540.500.390.310.280.00
Profit before tax(1.60)(1.64)(1.17)(0.84)(2.39)3.98(0.90)(0.63)
Tax0.000.000.000.00(0.04)(0.03)0.000.00
Net profit(1.60)(1.64)(1.17)(0.84)(2.35)4.01(0.90)(0.63)
EPS (₹)(21.40)(2.20)(1.53)(1.05)(3.00)5.39(1.16)(0.77)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue17.2324.7331.657.163.464.250.92
Revenue growth-30.3%-21.9%+342.0%+106.9%-18.6%+362.0%-
EBITDA(2.58)(0.90)(0.33)(2.54)(4.89)(0.04)(0.74)
EBITDA margin-15.0%-3.6%-1.0%-35.5%-141.3%-0.9%-80.4%
Profit before tax(3.67)3.120.27(2.77)(3.92)1.160.39
Net profit(3.63)3.330.23(2.75)(1.71)0.660.39
Net profit margin-21.1%+13.5%+0.7%-38.4%-49.4%+15.5%+42.4%
EPS (₹)(4.85)4.210.27(3.70)(11.55)2.891.14
Balance sheet
Total assets57.1849.2954.5755.1652.8459.0457.87
Net worth34.2137.8434.5834.3827.1333.5432.56
Total debt22.1611.220.271.086.025.835.64
Cash & bank0.670.380.520.180.270.050.02
Net working capital10.187.909.14(8.10)(6.12)(3.55)(2.42)
Cash flow
Cash from operations(4.50)(10.79)3.74(9.56)(2.79)(0.11)(0.56)
Cash from investing(4.40)0.53(2.78)4.392.81(0.04)(0.01)
Cash from financing9.0210.37(0.94)4.990.200.18(3.14)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue4.023.975.205.023.057.285.896.49
Revenue growth (YoY)+31.8%-45.5%-11.7%-22.7%-39.8%---
Other income0.170.290.180.670.164.380.120.13
Total expenses4.774.925.285.444.296.996.236.79
EBITDA(0.75)(0.95)(0.08)(0.42)(1.24)0.29(0.34)(0.30)
EBITDA margin-18.7%-23.9%-1.5%-8.4%-40.7%+4.0%-5.8%-4.6%
Depreciation0.120.120.120.060.060.090.030.02
Interest0.520.490.540.500.380.310.280.00
Profit before tax(1.22)(1.27)(0.56)(0.31)(1.52)4.27(0.53)(0.19)
Tax0.000.000.000.00(0.04)(0.03)0.000.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 20 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue4.884.925.695.923.217.656.186.90
Revenue growth (YoY)+52.0%-35.7%-7.9%-14.2%-39.2%---
Other income0.060.210.090.600.064.340.060.03
EBITDA(0.98)(1.17)(0.55)(0.83)(1.96)0.05(0.59)(0.58)
EBITDA margin-20.1%-23.8%-9.7%-14.0%-61.1%+0.7%-9.5%-8.4%
Depreciation0.160.180.170.110.100.100.090.08
Interest0.520.500.540.500.390.310.280.00
Profit before tax(1.60)(1.64)(1.17)(0.84)(2.39)3.98(0.90)(0.63)
Tax0.000.000.000.00(0.04)(0.03)0.000.00
Net profit(1.60)(1.64)(1.17)(0.84)(2.35)4.01(0.90)(0.63)
EPS (₹)(21.40)(2.20)(1.53)(1.05)(3.00)5.39(1.16)(0.77)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue19.7426.0132.237.353.554.250.92
Revenue growth-24.1%-19.3%+338.5%+107.0%-16.5%+362.0%-
Other income0.964.470.430.020.891.231.15
Total expenses24.1228.1634.4611.0110.135.141.75
Employee cost4.873.813.711.881.991.070.34
EBITDA(4.38)(2.15)(2.23)(3.66)(6.58)(0.89)(0.83)
EBITDA margin-22.2%-8.3%-6.9%-49.8%-185.4%-20.9%-90.2%
Depreciation0.560.350.300.370.170.030.01
Interest2.040.610.160.280.010.010.01
Profit before tax(6.02)1.36(2.26)(4.29)(5.87)0.300.30
Tax(0.04)(0.03)0.04(0.03)0.000.190.00
Net profit(5.80)1.78(1.96)(3.99)(2.92)(0.07)0.30
Net profit margin-29.4%+6.8%-6.1%-54.3%-82.3%-1.7%+32.6%
EPS (₹)(7.77)2.16(2.61)(5.35)(15.11)0.350.89
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital7.487.487.487.483.403.403.40
Reserves & surplus17.2223.0421.3123.2621.9329.1929.07
Shareholders' funds (net worth)24.7030.5228.7930.7425.3332.5932.47
Minority interest(1.49)(1.31)(1.10)(0.76)(1.11)0.000.00
Secured loans19.8511.090.140.080.090.000.00
Unsecured loans2.310.130.131.366.445.835.64
Total debt22.1611.220.271.446.535.835.64
Total liabilities46.1840.6547.6951.1250.4358.1057.80
Assets
Gross block18.0315.3318.1736.3055.5058.8758.03
Net block16.3014.0917.2835.7155.2858.8258.01
Capital work in progress0.350.100.100.100.020.060.00
Investments0.300.300.000.000.000.180.19
Inventories26.7328.4430.583.791.372.411.51
Sundry debtors6.246.778.514.691.902.521.78
Cash & bank balances0.780.410.540.210.280.070.02
Loans & advances10.106.415.850.771.011.051.77
Total current assets43.8542.0345.489.464.566.055.08
Total current liabilities36.3435.7536.1017.6911.009.637.63
Net working capital7.516.289.38(8.23)(6.44)(3.58)(2.55)
Total assets46.1840.6547.6951.1250.4358.1057.80
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.230.120.120.280.070.023.72
Net cash from operating activities(5.22)(10.08)1.95(10.87)(4.21)0.39(0.57)
Net cash from investing activities(3.59)(0.18)(0.64)5.844.22(0.51)0.00
Net cash from financing activities9.0210.37(1.30)4.870.190.18(3.14)
Net change in cash0.210.110.00(0.15)0.200.06(3.70)
Closing cash0.780.410.540.210.280.070.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-24.1%-19.3%+338.5%+107.0%-16.5%+362.0%-
EBITDA growth-103.7%+3.6%+39.1%+44.4%-639.3%-7.2%-
PBT growth-+9998.0%+47.3%+26.9%-0.0%+9998.0%
Net income growth-425.8%+190.8%+50.9%-36.6%-4071.4%-123.3%-
Revenue CAGR (3Y)+39.0%+94.2%+96.5%+99.9%+107.0%--
EBITDA CAGR (3Y)+6.2%-31.1%+35.8%+64.0%+96.3%--
Profitability & leverage
Net income margin-30.3%+5.3%-7.1%-58.0%-165.4%+2.6%+32.6%
Return on capital employed-8.9%+4.8%-4.2%-7.8%-5.2%-0.1%+0.5%
Return on net worth-21.7%+5.3%-7.7%-15.2%-8.1%-0.1%+0.9%
Debt / equity0.600.190.030.140.210.180.17
Long-term debt / equity0.160.000.000.000.000.000.00
Interest cover-41.30-24.40-6.32-6.95-0.15-1.09-1.19
Efficiency & per share
Fixed asset turnover1.181.551.180.160.060.070.02
Inventory turnover0.720.881.882.851.882.170.57
Debtors turnover3.033.404.882.231.611.980.56
EPS (₹)(7.77)2.16(2.61)(5.35)(15.11)0.350.89
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)33.0340.8138.5041.1174.5195.7695.41
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue4.023.975.205.023.057.285.896.49
Revenue growth (YoY)+31.8%-45.5%-11.7%-22.7%-39.8%---
Other income0.170.290.180.670.164.380.120.13
Total expenses4.774.925.285.444.296.996.236.79
EBITDA(0.75)(0.95)(0.08)(0.42)(1.24)0.29(0.34)(0.30)
EBITDA margin-18.7%-23.9%-1.5%-8.4%-40.7%+4.0%-5.8%-4.6%
Depreciation0.120.120.120.060.060.090.030.02
Interest0.520.490.540.500.380.310.280.00
Profit before tax(1.22)(1.27)(0.56)(0.31)(1.52)4.27(0.53)(0.19)
Tax0.000.000.000.00(0.04)(0.03)0.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue17.2324.7331.657.163.464.250.92
Revenue growth-30.3%-21.9%+342.0%+106.9%-18.6%+362.0%-
Other income1.304.780.820.231.021.231.15
Total expenses19.8125.6331.989.708.354.291.66
Employee cost2.072.132.091.050.910.560.26
EBITDA(2.58)(0.90)(0.33)(2.54)(4.89)(0.04)(0.74)
EBITDA margin-15.0%-3.6%-1.0%-35.5%-141.3%-0.9%-80.4%
Depreciation0.350.160.070.190.040.020.01
Interest2.040.600.150.270.010.010.01
Profit before tax(3.67)3.120.27(2.77)(3.92)1.160.39
Tax(0.04)(0.03)0.04(0.02)0.000.180.00
Net profit(3.63)3.330.23(2.75)(1.71)0.660.39
Net profit margin-21.1%+13.5%+0.7%-38.4%-49.4%+15.5%+42.4%
EPS (₹)(4.85)4.210.27(3.70)(11.55)2.891.14
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital7.487.487.487.483.403.403.40
Reserves & surplus26.7330.3627.1026.9023.7330.1429.16
Shareholders' funds (net worth)34.2137.8434.5834.3827.1333.5432.56
Secured loans19.8511.090.140.080.090.000.00
Unsecured loans2.310.130.131.005.935.835.64
Total debt22.1611.220.271.086.025.835.64
Total liabilities57.1849.2954.5755.1652.8459.0457.87
Assets
Gross block16.5614.1017.1935.3954.7758.4658.03
Net block15.7713.6016.8535.1254.6958.4258.01
Capital work in progress0.250.000.000.000.000.000.00
Investments2.061.620.910.520.170.190.19
Inventories26.7228.4430.583.791.372.411.51
Sundry debtors6.136.748.454.671.852.521.78
Cash & bank balances0.670.380.520.180.270.050.02
Loans & advances9.926.194.790.600.900.941.83
Total current assets43.4441.7544.349.244.395.925.14
Total current liabilities33.2633.8535.2017.3410.519.477.56
Net working capital10.187.909.14(8.10)(6.12)(3.55)(2.42)
Total assets57.1849.2954.5755.1652.8459.0457.87
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.210.100.090.270.050.023.72
Net cash from operating activities(4.50)(10.79)3.74(9.56)(2.79)(0.11)(0.56)
Net cash from investing activities(4.40)0.53(2.78)4.392.81(0.04)(0.01)
Net cash from financing activities9.0210.37(0.94)4.990.200.18(3.14)
Net change in cash0.130.110.01(0.18)0.220.03(3.70)
Closing cash0.670.380.520.180.270.050.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-30.3%-21.9%+342.0%+106.9%-18.6%+362.0%-
EBITDA growth-186.7%-172.7%+87.0%+48.1%-+94.6%-
PBT growth-+1055.6%+9998.0%+29.3%-+197.4%+9998.0%
Net income growth-209.0%+1347.8%+108.4%-60.8%-359.1%+69.2%-
Revenue CAGR (3Y)+34.0%+92.6%+95.3%+98.2%+105.3%--
EBITDA CAGR (3Y)+0.5%-43.1%+102.1%+50.9%+77.8%-65.6%+0.9%
Profitability & leverage
Net income margin-21.1%+12.7%+0.7%-38.4%-113.3%+23.1%+42.4%
Return on capital employed-3.1%+7.2%+0.7%-4.7%-2.4%+1.1%+0.7%
Return on net worth-10.1%+8.7%+0.6%-9.0%-3.7%+1.4%+1.2%
Debt / equity0.460.160.020.120.200.170.17
Long-term debt / equity0.120.000.000.000.000.000.00
Interest cover-69.62-56.60-37.50-9.89-0.20-16.67-1.33
Efficiency & per share
Fixed asset turnover1.121.581.200.160.060.070.02
Inventory turnover0.620.841.842.781.832.170.57
Debtors turnover2.683.264.822.201.581.980.56
EPS (₹)(4.85)4.210.27(3.70)(11.55)2.891.14
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)45.7550.6146.2445.9779.8298.6795.78
Want more history and ratios?
You're viewing the latest exchange-filed financials for TCM Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Board of Directors of TCM Limited

TCM has 8 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rani JoseDirector26 Mar 201511 Years 6 MonthsCurrent
Joseph VargheseManaging Director31 Dec 200520 Years 9 MonthsCurrent
Jose JacobDirector29 Sep 20215 Years 0 MonthsCurrent
Gopalakrishnan MaheshDirector29 Sep 20215 Years 0 MonthsCurrent
George VargheseDirector19 Jan 200719 Years 9 MonthsCurrent
Ramesh BabuDirector29 Sep 20224 Years 0 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer Comparison of TCM Limited

TCM Limited is compared with the companies closest to it by revenue in the Agriculture industry (Animal Feeds, Healthcare Equipment Retail and Distribution, Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Asomiya Mahila Poultry Producer Company Limited₹30.74 Cr (FY 2024)••••••••57.0%••••Moran, Assam, India
Odisha State Medical Corporation Limited₹30.61 Cr (FY 2022)••••••••31.0%••••Bhubaneswar, Odisha, India
Variety Vyapaar Pvt Ltd₹30.58 Cr (FY 2024)••••••••37.0%••••Kolkata, West Bengal, India
Versatile Specialty Chemicals Limited₹30.55 Cr (FY 2024)••••••••388.0%••••Dhule, Maharashtra, India
Gargi Chemicals Private Limited₹30.54 Cr (FY 2025)••••••••5.0%••••Mumbai, Maharashtra, India
Calcutta Medisolutions Private Limited₹30.46 Cr (FY 2025)••••••••49.0%••••Kolkata, West Bengal, India
Sushen Medicamentos Private Limited₹30.42 Cr (FY 2025)••••••••1.0%••••Ahmedabad, Gujarat, India
Kashiram Juglal Exim Private Limited₹30.41 Cr (FY 2025)••••••••14.0%••••Shahjahanpur, Uttar Pradesh, India
Kaeros Research Limited₹30.4 Cr (FY 2025)••••••••5198.0%••••Delhi, India
Clean Solar Power (Dhar) Private Limited₹30.35 Cr (FY 2025)••••••••2.0%••••New Delhi, Delhi, India
TCM Limited this company₹19.74 Cr (FY 2026)••••••••-24.1%••••Kochi, Kerala, India

Peers are the five companies nearest above and the five nearest below TCM by revenue in the Agriculture industry (Animal Feeds, Healthcare Equipment Retail and Distribution, Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of TCM Limited

TCM Limited is audited by S G M & Associates LLP for the financial year 2023.

NameStatusAppointment DateCessation Date
S G M & Associates LLPLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Shareholding Pattern of TCM Limited

Shareholding for the quarter ended Mar 2026: promoters hold 49.50%, foreign institutional investors hold 0.00%, domestic institutional investors hold 7.40% and retail and other public shareholders hold 43.10%.

Promoters: 49.50%DII (Domestic Institutional): 7.40%Retail & Others: 43.10%
Mar 2026
QUARTER
49.50% Promoters
7.40% DII (Domestic Institutional)
43.10% Retail & Others
Promoter holding - history
Now 49.50% · Mar 2026High 49.50% · Jun 2025Low 49.50% · Jun 2025
48%48.8%49.5%50.3%51%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 49.50%Sep 2025: 49.50%Dec 2025: 49.50%Mar 2026: 49.50%49.50%49.50%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters49.50%49.50%49.50%49.50%
Public50.50%50.50%50.50%50.50%

Charges & Borrowings of TCM Limited

Open charges
₹24.68 Cr
Satisfied charges
₹39.86 Cr
Breakdown by lending institutions
Others₹11.00 Cr
Indian Bank₹8.80 Cr
The Industrial Credit and Investment Corporation of India L₹3.50 Cr
The Industrial Finance Corporation of India Ltd₹1.38 Cr
Latest charge details
DateLenderAmountStatus
20 Feb 2026Indian Bank₹1.37 CrOpen
31 May 2025Indian Bank₹7.43 CrOpen
16 Oct 2024Others₹11 CrOpen
16 Feb 1996The Industrial Finance Corporation of India Ltd₹1.38 CrOpen
31 Jan 1995The Industrial Credit and Investment Corporation of India L₹1.5 CrOpen

Total charge records: 24 View all charges

Deals & Funding of TCM Limited

TCM Limited has 18 deals on record (17 market trades, 1 rights issue); the latest was in May 2026.

Total deals
18
Market trades
17
Rights issue
1

Deals on record (5 of 18)

WhenDealAmountParties
May 2026Market trade₹20.1 LakhBuyer: an individual
Nov 2023Market trade₹41.1 LakhBuyer: Multiplier Share and Stock Advisors Private Limited
Seller: Multiplier Share and Stock Advisors Private Limited
Nov 2023Market trade₹23 LakhBuyer: Multiplier Share and Stock Advisors Private Limited
Aug 2023Market trade₹24 LakhSeller: Dhwaja Shares & Securities Private Limited
Dec 2017Market trade₹38.8 LakhBuyer: Amit Jasani Financial Services Private Limited
Seller: an individual
Premium access

Full deal history

All 18 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Employees and EPFO Compliance at TCM Limited

Employment history and EPFO contributions of people linked to TCM.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of TCM Limited

TCM has 1 subsidiary company. This group structure data is as of FY 2020. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key Subsidiaries
Company NameCINShares Held
Ispark Learning Solutions Private LimitedU74999KL2020PTC061044-

Showing major subsidiaries. Total: 1.

Recent Activity on TCM Limited

TCM Limited has 27 board changes on record since 2005: 18 appointments and 9 cessations. The latest: Bobby John was appointed as Director on 31 Dec 2022.

Charges
A charge with Indian Bank amounted to Rs. 1.37 Cr with Charge ID 101249841 was registered on 20 Feb 2026.
Charges
A charge with Indian Bank of Rs. 7.43 Cr registered on 31 May 2025 with Charge ID 101109885 was modified on 20 Feb 2026.
AGM
Tcm Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Charges
A charge with Indian Bank amounted to Rs. 7.43 Cr with Charge ID 101109885 was registered on 31 May 2025.
Filing
Tcm Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge registered on 07 Jan 2009 via Charge ID 10135998 with Godrej Properties Limited was fully satisfied on 03 Mar 2025.
Charges
A charge with Others amounted to Rs. 11.00 Cr with Charge ID 101035773 was registered on 16 Oct 2024.
Appointed
Bobby John was appointed as Director.
Appointed
Sreenivasa Bhat Sadananda was appointed as Director.
Appointed
Ramesh Babu was appointed as Director.
Ceased
Shibu Chandran Chathengattil ceased to be Director.
Appointed
Gopalakrishnan Mahesh was appointed as Director.

74 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for TCM Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by TCM Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of TCM Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of TCM Limited

TCM has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
32AAACT6206A1Z4KeralaActive01 Jul 2017
33AAACT6206A3Z0Tamil NaduActive12 Apr 2018
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of TCM Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about TCM Limited

TCM is an active public limited company based in Kochi, Kerala, India. The company works in animal feeds, within the agriculture industry. It was incorporated on 20 April 1943 (83+ years old) and is registered under CIN L24299KL1943PLC001192. Listed on BSE: 524156.

TCM reported revenue of ₹19.74 Cr for FY 2025-26 (down 24.1% YoY) based on consolidated financials.

TCM has 8 current directors:

The GSTIN of TCM is 32AAACT6206A1Z4, registered in Kerala. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 33AAACT6206A3Z0 (Tamil Nadu).

The CIN (Corporate Identification Number) of TCM is L24299KL1943PLC001192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. TCM is listed on BSE with code 524156.

TCM has 70 court cases on record: 33 filed by the company and 24 filed against it. 7 are pending. Most are in the high courts.

TCM was incorporated on 20 April 1943, making it 83+ years old. It is registered with the Registrar of Companies, Ernakulam.

TCM has 18 deals on record (17 market trades, 1 rights issue); the latest was in May 2026.

The peers of TCM by revenue are Asomiya Mahila Poultry Producer Company Limited, Odisha State Medical Corporation Limited, Variety Vyapaar Pvt Ltd, Versatile Specialty Chemicals Limited, Gargi Chemicals Private Limited and 5 more, all in the Agriculture industry (Animal Feeds, Healthcare Equipment Retail and Distribution, Industrial Chemicals).

Bobby John was appointed as Director on 31 Dec 2022. Sreenivasa Bhat Sadananda was appointed as Director on 31 Dec 2022. Ramesh Babu was appointed as Director on 29 Sep 2022. TCM has 27 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available